As of May 26
| +0.74 / +1.56%|
The 9 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 57.00, with a high estimate of 90.00 and a low estimate of 47.00. The median estimate represents a +18.26% increase from the last price of 48.20.
The current consensus among 10 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.